Social mobilisation, drug coverage and compliance and adverse reactions in a Mass Drug Administration (MDA) Programme for the Elimination of Lymphatic Filariasis in Sri Lanka

Files in this item

This item appears in the following Collection(s)

Search DSpace


Browse

My Account